title: Palmar-plantar erythrodysaesthesia syndrome due to 5-fluorouracil therapy--an underestimated toxic event?
authors.affiliation: Istituto di Scienze Mediche, Università degli Studi, Milano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Iurlo
authors.forename: M
authors.initials: M
authors.lastname: Fornier
authors.forename: S
authors.initials: S
authors.lastname: Caldiera
authors.forename: F
authors.initials: F
authors.lastname: Bertoni
authors.forename: P
authors.initials: P
authors.lastname: Foa
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D002955:Leucovorin / Q000008:administration & dosage; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced*; D013577:Syndrome
chemical_list: D000964:Antimetabolites, Antineoplastic; D002955:Leucovorin; D005472:Fluorouracil